aluates Reports

$ 0.0

Automative

Global Oral Anticoagulant Reversal Drug Market Research Report 2025

Published Date: February 2025

Report Code: QYRE-Auto-4K15060

Global Oral Anticoagulant Reversal Drug Market Insights Forecast to 2029

BUY CHAPTERS

Global Oral Anticoagulant Reversal Drug Market Research Report 2025

Code: QYRE-Auto-4K15060

Report

February 2025

Pages:76

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Bausch Health Companies

Pfizer Inc

Fresenius Kabi

Amneal Pharmaceuticals

Boehringer Ingelheim

CSL Limited

Octapharma AG

Portola Pharmaceuticals

Perosphere Pharmaceuticals

Oral Anticoagulant Reversal Drug Market

The global market for Oral Anticoagulant Reversal Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.

Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.

This report aims to provide a comprehensive presentation of the global market for Oral Anticoagulant Reversal Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Anticoagulant Reversal Drug.

The Oral Anticoagulant Reversal Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oral Anticoagulant Reversal Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Oral Anticoagulant Reversal Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Oral Anticoagulant Reversal Drug Market Report

Report Metric	Details
Report Name	Oral Anticoagulant Reversal Drug Market
Segment by Type	Prothrombin Complex Concentrates Vitamin K Protamine Tranexamic Acid
Segment by Application	Hospital Pharmacies Retail Pharmacies Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Bausch Health Companies, Pfizer, Fresenius Kabi, Amneal Pharmaceuticals, Boehringer Ingelheim, CSL, Octapharma, Portola Pharmaceuticals, Perosphere Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oral Anticoagulant Reversal Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Oral Anticoagulant Reversal Drug Market report?

Ans: The main players in the Oral Anticoagulant Reversal Drug Market are Bausch Health Companies, Pfizer, Fresenius Kabi, Amneal Pharmaceuticals, Boehringer Ingelheim, CSL, Octapharma, Portola Pharmaceuticals, Perosphere Pharmaceuticals

What are the Application segmentation covered in the Oral Anticoagulant Reversal Drug Market report?

Ans: The Applications covered in the Oral Anticoagulant Reversal Drug Market report are Hospital Pharmacies, Retail Pharmacies, Others

What are the Type segmentation covered in the Oral Anticoagulant Reversal Drug Market report?

Ans: The Types covered in the Oral Anticoagulant Reversal Drug Market report are Prothrombin Complex Concentrates, Vitamin K, Protamine, Tranexamic Acid

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Oral Anticoagulant Reversal Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Prothrombin Complex Concentrates

1.2.3 Vitamin K

1.2.4 Protamine

1.2.5 Tranexamic Acid

1.3 Market by Application

1.3.1 Global Oral Anticoagulant Reversal Drug Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Oral Anticoagulant Reversal Drug Market Perspective (2020-2031)

2.2 Global Oral Anticoagulant Reversal Drug Growth Trends by Region

2.2.1 Global Oral Anticoagulant Reversal Drug Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Oral Anticoagulant Reversal Drug Historic Market Size by Region (2020-2025)

2.2.3 Oral Anticoagulant Reversal Drug Forecasted Market Size by Region (2026-2031)

2.3 Oral Anticoagulant Reversal Drug Market Dynamics

2.3.1 Oral Anticoagulant Reversal Drug Industry Trends

2.3.2 Oral Anticoagulant Reversal Drug Market Drivers

2.3.3 Oral Anticoagulant Reversal Drug Market Challenges

2.3.4 Oral Anticoagulant Reversal Drug Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Oral Anticoagulant Reversal Drug Players by Revenue

3.1.1 Global Top Oral Anticoagulant Reversal Drug Players by Revenue (2020-2025)

3.1.2 Global Oral Anticoagulant Reversal Drug Revenue Market Share by Players (2020-2025)

3.2 Global Oral Anticoagulant Reversal Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Oral Anticoagulant Reversal Drug Revenue

3.4 Global Oral Anticoagulant Reversal Drug Market Concentration Ratio

3.4.1 Global Oral Anticoagulant Reversal Drug Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Oral Anticoagulant Reversal Drug Revenue in 2024

3.5 Global Key Players of Oral Anticoagulant Reversal Drug Head office and Area Served

3.6 Global Key Players of Oral Anticoagulant Reversal Drug, Product and Application

3.7 Global Key Players of Oral Anticoagulant Reversal Drug, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Oral Anticoagulant Reversal Drug Breakdown Data by Type

4.1 Global Oral Anticoagulant Reversal Drug Historic Market Size by Type (2020-2025)

4.2 Global Oral Anticoagulant Reversal Drug Forecasted Market Size by Type (2026-2031)

5 Oral Anticoagulant Reversal Drug Breakdown Data by Application

5.1 Global Oral Anticoagulant Reversal Drug Historic Market Size by Application (2020-2025)

5.2 Global Oral Anticoagulant Reversal Drug Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Oral Anticoagulant Reversal Drug Market Size (2020-2031)

6.2 North America Oral Anticoagulant Reversal Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Oral Anticoagulant Reversal Drug Market Size by Country (2020-2025)

6.4 North America Oral Anticoagulant Reversal Drug Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Oral Anticoagulant Reversal Drug Market Size (2020-2031)

7.2 Europe Oral Anticoagulant Reversal Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Oral Anticoagulant Reversal Drug Market Size by Country (2020-2025)

7.4 Europe Oral Anticoagulant Reversal Drug Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Oral Anticoagulant Reversal Drug Market Size (2020-2031)

8.2 Asia-Pacific Oral Anticoagulant Reversal Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Oral Anticoagulant Reversal Drug Market Size by Region (2020-2025)

8.4 Asia-Pacific Oral Anticoagulant Reversal Drug Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Oral Anticoagulant Reversal Drug Market Size (2020-2031)

9.2 Latin America Oral Anticoagulant Reversal Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Oral Anticoagulant Reversal Drug Market Size by Country (2020-2025)

9.4 Latin America Oral Anticoagulant Reversal Drug Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Oral Anticoagulant Reversal Drug Market Size (2020-2031)

10.2 Middle East & Africa Oral Anticoagulant Reversal Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Oral Anticoagulant Reversal Drug Market Size by Country (2020-2025)

10.4 Middle East & Africa Oral Anticoagulant Reversal Drug Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Bausch Health Companies

11.1.1 Bausch Health Companies Company Details

11.1.2 Bausch Health Companies Business Overview

11.1.3 Bausch Health Companies Oral Anticoagulant Reversal Drug Introduction

11.1.4 Bausch Health Companies Revenue in Oral Anticoagulant Reversal Drug Business (2020-2025)

11.1.5 Bausch Health Companies Recent Development

11.2 Pfizer

11.2.1 Pfizer Company Details

11.2.2 Pfizer Business Overview

11.2.3 Pfizer Oral Anticoagulant Reversal Drug Introduction

11.2.4 Pfizer Revenue in Oral Anticoagulant Reversal Drug Business (2020-2025)

11.2.5 Pfizer Recent Development

11.3 Fresenius Kabi

11.3.1 Fresenius Kabi Company Details

11.3.2 Fresenius Kabi Business Overview

11.3.3 Fresenius Kabi Oral Anticoagulant Reversal Drug Introduction

11.3.4 Fresenius Kabi Revenue in Oral Anticoagulant Reversal Drug Business (2020-2025)

11.3.5 Fresenius Kabi Recent Development

11.4 Amneal Pharmaceuticals

11.4.1 Amneal Pharmaceuticals Company Details

11.4.2 Amneal Pharmaceuticals Business Overview

11.4.3 Amneal Pharmaceuticals Oral Anticoagulant Reversal Drug Introduction

11.4.4 Amneal Pharmaceuticals Revenue in Oral Anticoagulant Reversal Drug Business (2020-2025)

11.4.5 Amneal Pharmaceuticals Recent Development

11.5 Boehringer Ingelheim

11.5.1 Boehringer Ingelheim Company Details

11.5.2 Boehringer Ingelheim Business Overview

11.5.3 Boehringer Ingelheim Oral Anticoagulant Reversal Drug Introduction

11.5.4 Boehringer Ingelheim Revenue in Oral Anticoagulant Reversal Drug Business (2020-2025)

11.5.5 Boehringer Ingelheim Recent Development

11.6 CSL

11.6.1 CSL Company Details

11.6.2 CSL Business Overview

11.6.3 CSL Oral Anticoagulant Reversal Drug Introduction

11.6.4 CSL Revenue in Oral Anticoagulant Reversal Drug Business (2020-2025)

11.6.5 CSL Recent Development

11.7 Octapharma

11.7.1 Octapharma Company Details

11.7.2 Octapharma Business Overview

11.7.3 Octapharma Oral Anticoagulant Reversal Drug Introduction

11.7.4 Octapharma Revenue in Oral Anticoagulant Reversal Drug Business (2020-2025)

11.7.5 Octapharma Recent Development

11.8 Portola Pharmaceuticals

11.8.1 Portola Pharmaceuticals Company Details

11.8.2 Portola Pharmaceuticals Business Overview

11.8.3 Portola Pharmaceuticals Oral Anticoagulant Reversal Drug Introduction

11.8.4 Portola Pharmaceuticals Revenue in Oral Anticoagulant Reversal Drug Business (2020-2025)

11.8.5 Portola Pharmaceuticals Recent Development

11.9 Perosphere Pharmaceuticals

11.9.1 Perosphere Pharmaceuticals Company Details

11.9.2 Perosphere Pharmaceuticals Business Overview

11.9.3 Perosphere Pharmaceuticals Oral Anticoagulant Reversal Drug Introduction

11.9.4 Perosphere Pharmaceuticals Revenue in Oral Anticoagulant Reversal Drug Business (2020-2025)

11.9.5 Perosphere Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Bausch Health Companies

Pfizer Inc

Fresenius Kabi

Amneal Pharmaceuticals

Boehringer Ingelheim

CSL Limited

Octapharma AG

Portola Pharmaceuticals

Perosphere Pharmaceuticals

List of Tables

Table 1. Global Oral Anticoagulant Reversal Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Prothrombin Complex Concentrates

Table 3. Key Players of Vitamin K

Table 4. Key Players of Protamine

Table 5. Key Players of Tranexamic Acid

Table 6. Global Oral Anticoagulant Reversal Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Oral Anticoagulant Reversal Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Oral Anticoagulant Reversal Drug Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Oral Anticoagulant Reversal Drug Market Share by Region (2020-2025)

Table 10. Global Oral Anticoagulant Reversal Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Oral Anticoagulant Reversal Drug Market Share by Region (2026-2031)

Table 12. Oral Anticoagulant Reversal Drug Market Trends

Table 13. Oral Anticoagulant Reversal Drug Market Drivers

Table 14. Oral Anticoagulant Reversal Drug Market Challenges

Table 15. Oral Anticoagulant Reversal Drug Market Restraints

Table 16. Global Oral Anticoagulant Reversal Drug Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Oral Anticoagulant Reversal Drug Market Share by Players (2020-2025)

Table 18. Global Top Oral Anticoagulant Reversal Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Anticoagulant Reversal Drug as of 2024)

Table 19. Ranking of Global Top Oral Anticoagulant Reversal Drug Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Oral Anticoagulant Reversal Drug Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Oral Anticoagulant Reversal Drug, Headquarters and Area Served

Table 22. Global Key Players of Oral Anticoagulant Reversal Drug, Product and Application

Table 23. Global Key Players of Oral Anticoagulant Reversal Drug, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Oral Anticoagulant Reversal Drug Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Oral Anticoagulant Reversal Drug Revenue Market Share by Type (2020-2025)

Table 27. Global Oral Anticoagulant Reversal Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Oral Anticoagulant Reversal Drug Revenue Market Share by Type (2026-2031)

Table 29. Global Oral Anticoagulant Reversal Drug Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Oral Anticoagulant Reversal Drug Revenue Market Share by Application (2020-2025)

Table 31. Global Oral Anticoagulant Reversal Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Oral Anticoagulant Reversal Drug Revenue Market Share by Application (2026-2031)

Table 33. North America Oral Anticoagulant Reversal Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Oral Anticoagulant Reversal Drug Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Oral Anticoagulant Reversal Drug Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Oral Anticoagulant Reversal Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Oral Anticoagulant Reversal Drug Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Oral Anticoagulant Reversal Drug Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Oral Anticoagulant Reversal Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Oral Anticoagulant Reversal Drug Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Oral Anticoagulant Reversal Drug Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Oral Anticoagulant Reversal Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Oral Anticoagulant Reversal Drug Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Oral Anticoagulant Reversal Drug Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Oral Anticoagulant Reversal Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Oral Anticoagulant Reversal Drug Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Oral Anticoagulant Reversal Drug Market Size by Country (2026-2031) & (US$ Million)

Table 48. Bausch Health Companies Company Details

Table 49. Bausch Health Companies Business Overview

Table 50. Bausch Health Companies Oral Anticoagulant Reversal Drug Product

Table 51. Bausch Health Companies Revenue in Oral Anticoagulant Reversal Drug Business (2020-2025) & (US$ Million)

Table 52. Bausch Health Companies Recent Development

Table 53. Pfizer Company Details

Table 54. Pfizer Business Overview

Table 55. Pfizer Oral Anticoagulant Reversal Drug Product

Table 56. Pfizer Revenue in Oral Anticoagulant Reversal Drug Business (2020-2025) & (US$ Million)

Table 57. Pfizer Recent Development

Table 58. Fresenius Kabi Company Details

Table 59. Fresenius Kabi Business Overview

Table 60. Fresenius Kabi Oral Anticoagulant Reversal Drug Product

Table 61. Fresenius Kabi Revenue in Oral Anticoagulant Reversal Drug Business (2020-2025) & (US$ Million)

Table 62. Fresenius Kabi Recent Development

Table 63. Amneal Pharmaceuticals Company Details

Table 64. Amneal Pharmaceuticals Business Overview

Table 65. Amneal Pharmaceuticals Oral Anticoagulant Reversal Drug Product

Table 66. Amneal Pharmaceuticals Revenue in Oral Anticoagulant Reversal Drug Business (2020-2025) & (US$ Million)

Table 67. Amneal Pharmaceuticals Recent Development

Table 68. Boehringer Ingelheim Company Details

Table 69. Boehringer Ingelheim Business Overview

Table 70. Boehringer Ingelheim Oral Anticoagulant Reversal Drug Product

Table 71. Boehringer Ingelheim Revenue in Oral Anticoagulant Reversal Drug Business (2020-2025) & (US$ Million)

Table 72. Boehringer Ingelheim Recent Development

Table 73. CSL Company Details

Table 74. CSL Business Overview

Table 75. CSL Oral Anticoagulant Reversal Drug Product

Table 76. CSL Revenue in Oral Anticoagulant Reversal Drug Business (2020-2025) & (US$ Million)

Table 77. CSL Recent Development

Table 78. Octapharma Company Details

Table 79. Octapharma Business Overview

Table 80. Octapharma Oral Anticoagulant Reversal Drug Product

Table 81. Octapharma Revenue in Oral Anticoagulant Reversal Drug Business (2020-2025) & (US$ Million)

Table 82. Octapharma Recent Development

Table 83. Portola Pharmaceuticals Company Details

Table 84. Portola Pharmaceuticals Business Overview

Table 85. Portola Pharmaceuticals Oral Anticoagulant Reversal Drug Product

Table 86. Portola Pharmaceuticals Revenue in Oral Anticoagulant Reversal Drug Business (2020-2025) & (US$ Million)

Table 87. Portola Pharmaceuticals Recent Development

Table 88. Perosphere Pharmaceuticals Company Details

Table 89. Perosphere Pharmaceuticals Business Overview

Table 90. Perosphere Pharmaceuticals Oral Anticoagulant Reversal Drug Product

Table 91. Perosphere Pharmaceuticals Revenue in Oral Anticoagulant Reversal Drug Business (2020-2025) & (US$ Million)

Table 92. Perosphere Pharmaceuticals Recent Development

Table 93. Research Programs/Design for This Report

Table 94. Key Data Information from Secondary Sources

Table 95. Key Data Information from Primary Sources

Table 96. Authors List of This Report

List of Figures

Figure 1. Oral Anticoagulant Reversal Drug Picture

Figure 2. Global Oral Anticoagulant Reversal Drug Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Oral Anticoagulant Reversal Drug Market Share by Type: 2024 VS 2031

Figure 4. Prothrombin Complex Concentrates Features

Figure 5. Vitamin K Features

Figure 6. Protamine Features

Figure 7. Tranexamic Acid Features

Figure 8. Global Oral Anticoagulant Reversal Drug Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Oral Anticoagulant Reversal Drug Market Share by Application: 2024 VS 2031

Figure 10. Hospital Pharmacies Case Studies

Figure 11. Retail Pharmacies Case Studies

Figure 12. Others Case Studies

Figure 13. Oral Anticoagulant Reversal Drug Report Years Considered

Figure 14. Global Oral Anticoagulant Reversal Drug Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Oral Anticoagulant Reversal Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Oral Anticoagulant Reversal Drug Market Share by Region: 2024 VS 2031

Figure 17. Global Oral Anticoagulant Reversal Drug Market Share by Players in 2024

Figure 18. Global Top Oral Anticoagulant Reversal Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Anticoagulant Reversal Drug as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Oral Anticoagulant Reversal Drug Revenue in 2024

Figure 20. North America Oral Anticoagulant Reversal Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Oral Anticoagulant Reversal Drug Market Share by Country (2020-2031)

Figure 22. United States Oral Anticoagulant Reversal Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Oral Anticoagulant Reversal Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Oral Anticoagulant Reversal Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Oral Anticoagulant Reversal Drug Market Share by Country (2020-2031)

Figure 26. Germany Oral Anticoagulant Reversal Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Oral Anticoagulant Reversal Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Oral Anticoagulant Reversal Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Oral Anticoagulant Reversal Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Oral Anticoagulant Reversal Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Oral Anticoagulant Reversal Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Oral Anticoagulant Reversal Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Oral Anticoagulant Reversal Drug Market Share by Region (2020-2031)

Figure 34. China Oral Anticoagulant Reversal Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Oral Anticoagulant Reversal Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Oral Anticoagulant Reversal Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Oral Anticoagulant Reversal Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Oral Anticoagulant Reversal Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Oral Anticoagulant Reversal Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Oral Anticoagulant Reversal Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Oral Anticoagulant Reversal Drug Market Share by Country (2020-2031)

Figure 42. Mexico Oral Anticoagulant Reversal Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Oral Anticoagulant Reversal Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Oral Anticoagulant Reversal Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Oral Anticoagulant Reversal Drug Market Share by Country (2020-2031)

Figure 46. Turkey Oral Anticoagulant Reversal Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Oral Anticoagulant Reversal Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Oral Anticoagulant Reversal Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Bausch Health Companies Revenue Growth Rate in Oral Anticoagulant Reversal Drug Business (2020-2025)

Figure 50. Pfizer Revenue Growth Rate in Oral Anticoagulant Reversal Drug Business (2020-2025)

Figure 51. Fresenius Kabi Revenue Growth Rate in Oral Anticoagulant Reversal Drug Business (2020-2025)

Figure 52. Amneal Pharmaceuticals Revenue Growth Rate in Oral Anticoagulant Reversal Drug Business (2020-2025)

Figure 53. Boehringer Ingelheim Revenue Growth Rate in Oral Anticoagulant Reversal Drug Business (2020-2025)

Figure 54. CSL Revenue Growth Rate in Oral Anticoagulant Reversal Drug Business (2020-2025)

Figure 55. Octapharma Revenue Growth Rate in Oral Anticoagulant Reversal Drug Business (2020-2025)

Figure 56. Portola Pharmaceuticals Revenue Growth Rate in Oral Anticoagulant Reversal Drug Business (2020-2025)

Figure 57. Perosphere Pharmaceuticals Revenue Growth Rate in Oral Anticoagulant Reversal Drug Business (2020-2025)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Anticoagulant Reversal Drug Market Insights Forecast to 2030

Global Anticoagulant Medications Market Research Report 2024

Global Anticoagulant Reversal Drugs Market Research Report 2024

Global Anticoagulant Injections Market Research Report 2025

Global Anticoagulant Medicine Market Research Report 2025

Global Direct Oral Anticoagulant Market Insights Forecast to 2030

Global Anti thrombotic Drugs Market Research Report 2024

Global Dibigatran Market Research Report 2024

Global Decoagulant Market Research Report 2024

Global Novel Oral Anticoagulants Drugs Market Insights Forecast to 2030

Global Oral Tranexamic Acid Market Research Report 2024

Global Anticoagulation Therapy Devices Market Research Report 2024

Global Anticoagulant Reversal Agent Market Research Report 2024

Global Hemostatic Agents Market Research Report 2025

Global Dabigatran Dabigatran Generic Drugs Market Research Report 2024

Global IV and Oral Iron Drugs Market Insights Forecast to 2030

Global Chronic Hepatitis B Treatment Oral Drugs Market Research Report 2024

Global Oral Peptide Therapeutics Market Research Report 2024

Global Anticoagulant Treatment Market Insights Forecast to 2030

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-19B19893

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-30B3636

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-3H1702

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-13C3384

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions